Daniel Brennan

Chief Commercial Officer at Catalyst Pharmaceuticals, Inc.

Daniel Brennan

Daniel Brennan

Chief Commercial Officer at Catalyst Pharmaceuticals, Inc.

Overview
Career Highlights

Edge Therapeutics, Inc.
INSYS Therapeutics, Inc.
PDS Biotechnology Corp.

RelSci Relationships

740

Number of Boards

2

Birthday

1968

Age

51

Relationships
RelSci Relationships are individuals Daniel Brennan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chairman, President & Chief Executive Officer at Horizon Therapeutics Plc

Relationship likelihood: Strong

Chief Executive Officer & President at TriSalus Life Sciences

Relationship likelihood: Strong

Chairman & Chief Executive Officer at TerSera Therapeutics LLC

Relationship likelihood: Strong

Co-Founder, Chairman, President & Chief Executive Officer at Catalyst Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder & Board of Directors at Catalyst Pharmaceuticals, Inc.

Relationship likelihood: Strong

President at Lundbeck, Inc.

Relationship likelihood: Strong

Head-Neurosurgery Division at St. Michael's Hospital

Relationship likelihood: Strong

Former Assistant Secretary at Edge Therapeutics, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Keracure, Inc.

Relationship likelihood: Strong

Senior Managing Director, Vice President & Head at Baxter Ventures

Relationship likelihood: Strong

Paths to Daniel Brennan
Potential Connections via
Relationship Science
You
Daniel Brennan
Chief Commercial Officer at Catalyst Pharmaceuticals, Inc.
Education

The University of Notre Dame’s endowment provides nearly $100 million in financial aid annually to help students pay for college. Less than a generation ago, in 1990, the number was around $5 million. They’ve been able to keep pace with the rapidly growing financial needs of students, in part, by making smart investments in private equity.

The Kellogg School of Management (The Kellogg School or Kellogg) is the business school of Northwestern University in Evanston, Illinois, with additional campuses in downtown Chicago, Illinois and Miami, Florida. Kellogg offers full-time, part-time, and executive programs, and partners with schools in China, France/Singapore, India, Hong Kong, Israel, Germany, Canada, and Thailand.Founded in 1908 in downtown Chicago as a part-time evening program, the school was chartered to educate business leaders with "good moral character.

Career History
Chief Commercial Officer
2018 - Current

Catalyst Pharmaceuticals is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasmsThe company was founded Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Chief Operating Officer
2016 - 2018

Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.

Chief Operating Officer & Executive Vice President
2015 - 2016

INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.

Boards & Committees
Member, Board of Directors
2014 - Current

The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Daniel Brennan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Daniel Brennan's profile does not indicate a business or promotional relationship of any kind between RelSci and Daniel Brennan.